New York, New York
Associate Professor of Surgery
New York University School of Medicine
Director, NYU Vein Center
New York University Medical Center
SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2014
Presenter
SESSION 23: OUTPATIENT TREATMENT, IMPROVING CARE, RCTS, REGISTRIES
What Organization(s) Should Set Standards, Accredit And Regulate Outpatient Vascular And Vein Diagnostic And Treatment Centers – Toward What Goals
4:10 PM - 4:15 PM
Thursday, November 20, 2014
Session Moderator
SESSION-64: VENOUS CLINICAL EXAMINATION AND SELECTING PATIENTS APPROPRIATELY
Session Moderator
SESSION-65: FIRST-LINE VENOUS IMAGING TECHNIQUES AND PHYSIOLOGIC TESTING
Session Moderator
SESSION-66: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
Session Moderator
SESSION-68: VENOUS SOCIETAL AND GOVERNANCE ISSUES
Presenter
SESSION 64: VENOUS CLINICAL EXAMINATION AND SELECTING PATIENTS APPROPRIATELY
What Duplex Ultrasound Mapping Adds To The Exam
6:55 AM - 7:00 AM
Presenter
SESSION 66: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
The Argument Against Mandatory Duplex Scanning Following Vein Ablation
9:01 AM - 9:06 AM
Presenter
SESSION 66: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
Go Green: Avoid Synthetic Venous Ablation
9:13 AM - 9:18 AM
Presenter
SESSION 66: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
Is 1920 Nanometer Wavelength The Future Of Venous Ablation
10:01 AM - 10:06 AM
Presenter
SESSION 68: VENOUS SOCIETAL AND GOVERNANCE ISSUES
IAC Vein Center: Importance And Update
11:07 AM - 11:12 AM
Presenter
SESSION 68: VENOUS SOCIETAL AND GOVERNANCE ISSUES
A National Coverage Determination Policy Is Needed
11:37 AM - 11:42 AM
Presenter
SESSION 70: CROSS-SECTIONAL VENOUS IMAGING TO CLARIFY DIFFICULT CLINICAL SCENARIOS
The Use Of IVUS To Document May Thurner Anatomy
3:19 PM - 3:24 PM
Friday, November 21, 2014
Session Moderator
SESSION-90: MORE STRATEGIC METHODS TO DEAL WITH SAPHENOUS INCOMPETENCE AND VARICOSE VEINS
Saturday, November 22, 2014
Session Moderator
SESSION-98: EVALUATION AND MANAGEMENT OF SUPERFICIAL VENOUS DISEASE - PART 1
Session Moderator
SESSION-97: BASICS OF SUPERFICIAL VENOUS DISEASE
Session Moderator
SESSION-99: EVALUATION AND MANAGEMENT OF SUPERFICIAL VENOUS DISEASE - PART 2
Session Moderator
SESSION-100: FUTURE OF VENOUS DISEASE
Session Moderator
SESSION-101: EVIDENCE AND RESEARCH NEEDED FOR ENDOVENOUS TREATMENT
Session Moderator
SESSION-102: MORE TOPICS REGARDING TRUNCAL REFLUX, CLUSTERS AND SPIDER TELANGIECTASIA
Session Moderator
SESSION-103: ENDOVENOUS CASE PRESENTATION, PRE-RECORDED VIDEO, EVIDENCE AND MORE
Presenter
SESSION 98: EVALUATION AND MANAGEMENT OF SUPERFICIAL VENOUS DISEASE - PART 1
What Determines The Clinical Severity Of Superficial Venous Disease
9:07 AM - 9:12 AM
Presenter
SESSION 98: EVALUATION AND MANAGEMENT OF SUPERFICIAL VENOUS DISEASE - PART 1
Step By Step Use Of Proprietary Foam For Saphenous Ablation And Indications
9:43 AM - 9:48 AM
Presenter
SESSION 99: EVALUATION AND MANAGEMENT OF SUPERFICIAL VENOUS DISEASE - PART 2
Steps To Avoid Thermal Skin Damage
10:49 AM - 10:54 AM
Presenter
SESSION 100: FUTURE OF VENOUS DISEASE
Update: Intersocietal Accreditation Commission – Vein Center
11:19 AM - 11:24 AM
Presenter
SESSION 100: FUTURE OF VENOUS DISEASE
A Plea For A National Coverage Determination Policy
11:31 AM - 11:36 AM
Presenter
SESSION 101: EVIDENCE AND RESEARCH NEEDED FOR ENDOVENOUS TREATMENT
DEBATE: Ultrasound Is Not Mandantory After Saphenous Ablation
1:30 PM - 1:35 PM
Presenter
SESSION 102: MORE TOPICS REGARDING TRUNCAL REFLUX, CLUSTERS AND SPIDER TELANGIECTASIA
Is 1920nm Wavelength The Future Of Venous Ablation
2:07 PM - 2:12 PM
Presenter
SESSION 102: MORE TOPICS REGARDING TRUNCAL REFLUX, CLUSTERS AND SPIDER TELANGIECTASIA
Homemade Foam Versus FDA Approved Manufactured Foam: Risks And Rewards
2:19 PM - 2:24 PM
Presenter
SESSION 102: MORE TOPICS REGARDING TRUNCAL REFLUX, CLUSTERS AND SPIDER TELANGIECTASIA
Laser Ablation Treatment Pearls
2:43 PM - 2:48 PM
 
previous next